Novel bioactivity of NHERF1 in corneal neovascularization
- PMID: 22777301
- DOI: 10.1007/s00417-012-2094-5
Novel bioactivity of NHERF1 in corneal neovascularization
Abstract
Purpose: This paper aimed to determine the involvement of Na(+)/H(+) exchanger regulatory factor 1 (NHERF1) in experimental murine corneal neovascularization (NV), and to study the effect of NHERF1 on the biological properties of HUVEC and related mechanisms.
Methods: Using loss- and gain-function, we investigated the biological effects of NHERF1 on HUVEC. Western blotting was used to detect the expression of NHERF1 in cells. A carboxyfluorescein succinimidyl ester (CFSE) labeling assay and scarification test were used to measure the proliferation and migration activity, respectively, of HUVEC. The cell cycle distribution of the cells was assessed by flow cytometry analysis. The effect of NHERF1 on the phosphorylation levels of Akt and the changes of matrix metalloproteinase (MMP)-2 and MMP-9 levels were detected by western blotting analysis. Change in the NHERF1 expression in the alkali burn-induced corneal NV model was detected by microarray, real-time PCR, and immunofluorescence.
Results: Overexpression of exogenous NHERF1 in HUVEC slightly inhibited the proliferation and significantly reduced the migration of the cells. NHERF1 also significantly downregulated Akt1 phosphorylation induced by platelet-derived growth factor BB (PDGF-BB) and the secretion of MMP-2 and MMP-9 compared with control cells. NHERF1 was upregulated in corneas challenged with alkali burns.
Conclusions: Our results indicated that NHERF1 might serve as a potential target for manipulating neovascularization-related diseases. This discovery contributes to a better understanding of the bioactivity of NHERF1 in angiogenesis.
Similar articles
-
Blockade of the intermediate-conductance Ca(2+)-activated K+ channel inhibits the angiogenesis induced by epidermal growth factor in the treatment of corneal alkali burn.Exp Eye Res. 2013 May;110:76-87. doi: 10.1016/j.exer.2013.02.015. Epub 2013 Mar 7. Exp Eye Res. 2013. PMID: 23482085
-
Cholesterol modification of SDF-1-specific siRNA enables therapeutic targeting of angiogenesis through Akt pathway inhibition.Exp Eye Res. 2019 Jul;184:64-71. doi: 10.1016/j.exer.2019.03.006. Epub 2019 Mar 19. Exp Eye Res. 2019. PMID: 30898556
-
Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4062-71. doi: 10.1167/iovs.04-1330. Invest Ophthalmol Vis Sci. 2005. PMID: 16249481
-
Rapamycin ameliorates corneal injury after alkali burn through methylation modification in mouse TSC1 and mTOR genes.Exp Eye Res. 2021 Feb;203:108399. doi: 10.1016/j.exer.2020.108399. Epub 2020 Dec 23. Exp Eye Res. 2021. PMID: 33352197
-
The Biological Relevance of NHERF1 Protein in Gynecological Tumors.Front Oncol. 2022 Feb 11;12:836630. doi: 10.3389/fonc.2022.836630. eCollection 2022. Front Oncol. 2022. PMID: 35223518 Free PMC article. Review.
Cited by
-
NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma.J Exp Clin Cancer Res. 2018 May 2;37(1):96. doi: 10.1186/s13046-018-0766-7. J Exp Clin Cancer Res. 2018. PMID: 29716631 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous